Hyperpituitarism (patient information)

Revision as of 20:10, 21 January 2012 by Lakshmi Gopalakrishnan (talk | contribs) (→‎What to expect (Outook/Prognosis)?)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

For the WikiDoc page for this topic, click here

Hyperpituitarism (patient information)
ICD-10 E22
ICD-9 253.1
MeSH D006964

WikiDoc Resources for Hyperpituitarism (patient information)

Articles

Most recent articles on Hyperpituitarism (patient information)

Most cited articles on Hyperpituitarism (patient information)

Review articles on Hyperpituitarism (patient information)

Articles on Hyperpituitarism (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperpituitarism (patient information)

Images of Hyperpituitarism (patient information)

Photos of Hyperpituitarism (patient information)

Podcasts & MP3s on Hyperpituitarism (patient information)

Videos on Hyperpituitarism (patient information)

Evidence Based Medicine

Cochrane Collaboration on Hyperpituitarism (patient information)

Bandolier on Hyperpituitarism (patient information)

TRIP on Hyperpituitarism (patient information)

Clinical Trials

Ongoing Trials on Hyperpituitarism (patient information) at Clinical Trials.gov

Trial results on Hyperpituitarism (patient information)

Clinical Trials on Hyperpituitarism (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperpituitarism (patient information)

NICE Guidance on Hyperpituitarism (patient information)

NHS PRODIGY Guidance

FDA on Hyperpituitarism (patient information)

CDC on Hyperpituitarism (patient information)

Books

Books on Hyperpituitarism (patient information)

News

Hyperpituitarism (patient information) in the news

Be alerted to news on Hyperpituitarism (patient information)

News trends on Hyperpituitarism (patient information)

Commentary

Blogs on Hyperpituitarism (patient information)

Definitions

Definitions of Hyperpituitarism (patient information)

Patient Resources / Community

Patient resources on Hyperpituitarism (patient information)

Discussion groups on Hyperpituitarism (patient information)

Patient Handouts on Hyperpituitarism (patient information)

Directions to Hospitals Treating Hyperpituitarism (patient information)

Risk calculators and risk factors for Hyperpituitarism (patient information)

Healthcare Provider Resources

Symptoms of Hyperpituitarism (patient information)

Causes & Risk Factors for Hyperpituitarism (patient information)

Diagnostic studies for Hyperpituitarism (patient information)

Treatment of Hyperpituitarism (patient information)

Continuing Medical Education (CME)

CME Programs on Hyperpituitarism (patient information)

International

Hyperpituitarism (patient information) en Espanol

Hyperpituitarism (patient information) en Francais

Business

Hyperpituitarism (patient information) in the Marketplace

Patents on Hyperpituitarism (patient information)

Experimental / Informatics

List of terms related to Hyperpituitarism (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Jinhui Wu, M.D.

Overview

Hyperpituitarism is the disorder of excess secretion of adenohypophyseal trophic hormones, which is commonly caused by a functional pituitary adenoma. Usual symptoms depend on the cell types affected. Common clinical manifestations of hormone excess may include hyperprolactinaemia, Cushing's disease, precocious puberty, gigantism or acromegaly. Usual signs and symptoms include headache, excessive sweating, hoarseness, galactorrhea, sleep apnea, osteoporosis and hypertension. Hormone tests and cranial MRI may help disgnosis. Treatments of hyperpituitarism focus on surgery to remove the tumor and inhibition of synthesis or secretion of such abnormal hormones.

What are the symptoms of hyperpituitarism?

Signs and symptoms of hyperpituitarism are the excessive production of growth hormone and abnormal hormone excretion controlled by the pituitary, such as prolactin and thyroid hormones.

Who is at highest risk?

Diagnosis

When to seek urgent medical care?

If you develop signs and symptoms associated with hyperpituitarism, see your doctor to determine the cause. If you experience either of the following symptoms, seeking urgent medical care as soon as possible:

Treatment options

Treatment opinion depends on the cause and the cell types affected.

Diseases with similar symptoms

Where to find medical care for hyperpituitarism?

Directions to Hospitals Treating hyperpituitarism

Prevention of hyperpituitarism

The prevention of hyperpituitarism is unknown.

What to expect (Outook/Prognosis)?

Prognosis of hyperpituitariam depends on the hormone level affected.

  • Whether the patient has been treated with surgery to remove the tumor.
  • For hyperprolactinemia: The undetectable level (<2 µg/L) of prolactin predicts cure with more than 90% probability. On the contrary, higher values within the reference range indicate incomplete removal of the adenoma.
  • Postoperative serum GH levels: Basal serum GH levels obtained immediately after surgery suggest the outcome of tumor recurrence in children with GH-releasing adenomas. The higher the GH levels are, the worse of the prognosis will be.
  • For hyperpituitariam resulting from corticotropinoma: The concentration of plasma cortisol concentration in the morning and corticotropin concentration over 24 consecutive hours measured 4-7 days after surgery may demonstrate the prognosis. The lower the concentrations are, the better outcomes will be.

Template:WH Template:WS